34687870 2025-01-01 2025-12-31 34687870 2025-01-01 2025-12-31 1 34687870 2025-01-01 2025-12-31 1 34687870 2025-01-01 2025-12-31 1 34687870 2025-01-01 2025-12-31 2 34687870 2025-01-01 2025-12-31 3 34687870 2025-01-01 2025-12-31 4 34687870 2025-01-01 2025-12-31 5 34687870 2024-01-01 2024-12-31 34687870 2025-12-31 34687870 2024-12-31 34687870 2025-01-01 2025-12-31 d:ContributedCapitalMember 34687870 2025-01-01 2025-12-31 d:RetainedEarningsMember 34687870 2025-01-01 2025-12-31 d:ReserveForDevelopmentExpenditureMember 34687870 2025-12-31 d:ContributedCapitalMember 34687870 2025-12-31 d:ReserveForDevelopmentExpenditureMember 34687870 2025-12-31 d:RetainedEarningsMember 34687870 2025-01-01 d:CompletedDevelopmentProjectsMember 34687870 2025-01-01 d:AcquiredIntangibleAssetsMember 34687870 2025-01-01 d:DevelopmentProjectsInProgressMember 34687870 2025-01-01 2025-12-31 d:DevelopmentProjectsInProgressMember 34687870 2025-12-31 d:CompletedDevelopmentProjectsMember 34687870 2025-12-31 d:AcquiredIntangibleAssetsMember 34687870 2025-12-31 d:DevelopmentProjectsInProgressMember 34687870 2025-01-01 2025-12-31 d:CompletedDevelopmentProjectsMember 34687870 2025-01-01 2025-12-31 d:AcquiredIntangibleAssetsMember 34687870 2025-01-01 d:LeaseholdImprovementsMember 34687870 2025-01-01 d:FixturesFittingsToolsAndEquipmentMember 34687870 2025-01-01 2025-12-31 d:FixturesFittingsToolsAndEquipmentMember 34687870 2025-12-31 d:LeaseholdImprovementsMember 34687870 2025-12-31 d:FixturesFittingsToolsAndEquipmentMember 34687870 2025-01-01 2025-12-31 d:LeaseholdImprovementsMember 34687870 2025-01-01 d:DepositsLongtermInvestmentsAndReceivablesMember 34687870 2025-01-01 2025-12-31 d:DepositsLongtermInvestmentsAndReceivablesMember 34687870 2025-12-31 d:DepositsLongtermInvestmentsAndReceivablesMember 34687870 2025-12-31 d:OtherPayablesIncludingTaxPayablesLiabilitiesOtherThanProvisionsLongtermMember 34687870 2024-12-31 d:LongtermBillsOfExchangePayableMember iso4217:DKK xbrli:pure Årsrapport Keld Friis Regnskabsklasse B Revisionspåtegning 2026-06-23 Beierholm Langagervej 1 9220 Aalborg Ø Opinion Basis for Opinion 2026-06-23 2024-01-01 2024-12-31 2025-01-01 Generatorvej 2025-12-31 34687870 32895468 Fida Biosystems ApS 8 D 2 th 2860 Søborg Søborg Beierholm Tangen 9 8200 Aarhus N Danmark true We have on this day presented the annual report for the financial year 01.01.25 - 31.12.25 for Fida Biosystems ApS. The annual report is presented in accordance with the Danish Finan­cial Sta­te­ments Act. In our opinion, the financial statements give a true and fair view of the company's assets, liabilities and financial position as at 31.12.25 and of the results of the company's activities for the financial year 01.01.25 - 31.12.25. The annual report is submitted for adoption by the general meeting. Brian Sørensen Ole Kring Chairman Ole Vorm Jay Teich Tonni Bülow-Nielsen Linus Wiebe To the capital owners of Fida Biosystems ApS In our opinion the fi­nan­cial sta­te­ments give a true and fair view of the company's finan­cial posi­tion at 31.12.25 and of the results of the company's ope­ra­tions for the finan­cial year 01.01.25 - 31.12.25 in ac­cor­dan­ce with the Danish Finan­cial Sta­te­ments Act. We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s responsibilities for the audit of the fi­nan­cial sta­te­ments” section of our report. We are independent of the company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Management is responsible for the pre­pa­ra­tion of fi­nan­cial sta­te­ments that give a true and fair view in ac­cor­dance with the Danish Finan­cial Sta­te­ments Act and for such in­ter­nal control as Mana­gement de­ter­mi­nes is necessary to enable the pre­pa­ra­tion of fi­nan­cial sta­te­ments that are free from material misstatement, whether due to fraud or error.In preparing the fi­nan­cial sta­te­ments, mana­ge­ment is responsible for assessing the company's ability to continue as a going concern, dis­closing, as applicable, mat­ters related to going con­cern and using the going concern basis of ac­counting in pre­paring the fi­nan­cial sta­te­ments unless mana­ge­ment either intends to liquidate the company or to cease operations, or has no rea­listic alternative but to do so. Our objectives are to obtain reasonable as­surance about whether the fi­nan­cial sta­te­ments as a whole are free from material mis­statement, whether due to fraud or error, and to issue an auditor’s report that inclu­des our opinion. Reasonable assurance is a high level of assurance, but is not a gua­ran­tee that an audit conducted in accor­dance with ISAs and the additional requirements applic­able in Denmark will always detect a material misstatement when it exists. Mis­sta­te­ments can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be ex­pec­ted to influence the economic decisions of users taken on the basis of these fi­nan­cial sta­te­ments.As part of an audit conducted in accordance with ISAs and the additional requirements applic­able in Denmark, we exercise pro­fes­sional judgment and maintain professional scepticism through­out the audit. We also: Identify and assess the risks of material misstatement of the fi­nan­cial sta­te­ments, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and ap­pro­priate to provide a basis for our opinion. The risk of not detecting a mate­rial misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, mis­repre­sen­tations, or the override of internal control.Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appro­priate in the cir­cum­stances, but not for the purpose of expres­sing an opinion on the effectiveness of the company's inter­nal control.Evaluate the appropriateness of accoun­ting policies used and the reason­able­ness of accounting estimates and related disclosures made by management.Conclude on the appropriateness of manage­ment’s use of the going concern basis of accoun­ting in preparing the fi­nan­cial sta­te­ments and, based on the audit evidence obtained, whether a mate­rial uncertainty exists related to events or conditions that may cast signi­ficant doubt on the company's ability to con­tinue as a going concern. If we con­clude that a material uncertainty exists, we are required to draw attention in our audi­tor’s report to the related disclosures in the fi­nan­cial sta­te­ments or, if such dis­closures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern.Evaluate the overall presentation, structure and contents of the fi­nan­cial sta­te­ments, including the disclosures, and whether the fi­nan­cial sta­te­ments repre­sent the underlying transactions and events in a manner that gives a true and fair view.We communicate with those charged with gover­nance regarding, among other mat­ters, the planned scope and timing of the audit and significant audit findings, inclu­ding any significant deficiencies in internal control that we identify during our audit. Aarhus Peter Vinstrup Henriksen State Authorised Public Accountant mne33244 15442530 3372652 26936369 19515473 4190987 4269059 -15684826 -20411880 105937 181293 941710 476650 -16520599 -20707237 -2700000 -1000000 -13820599 -19707237 -13820599 -19707237 5271429 9174497 22190 40585 2266009 0 7559628 9215082 36304 103447 1654632 278152 1690936 381599 345118 327815 345118 327815 9595682 9924496 5735062 10662767 1023691 1370000 6758753 12032767 14090445 12976496 6400000 3700000 187715 340741 180337 181717 20858497 17198954 36353928 11127748 63971178 40359469 73566860 50283965 333643 269683 5788662 7065568 55068609 29939790 61190914 37275041 3620533 4422328 3620533 4422328 835200 751255 3823881 1824569 1176157 591361 2920175 5419411 8755413 8586596 12375946 13008924 73566860 50283965 Figures in DKKShare capitalReserve for development costsRetained earningsStatement of changes in equity for 01.01.25 - 31.12.25Balance as at 01.01.25269,6837,065,56829,939,790Capital increase63,960037,672,512Transfers to/from other reserves0-1,276,9061,276,906Net profit/loss for the year00-13,820,599Balance as at 31.12.25333,6435,788,66255,068,609 63960 37672512 -1276906 1276906 -13820599 333643 5788662 55068609 1.Primary activitiesThe company's activities comprise research and development of point-of-care technologies and related business. 26455482 18889598 383177 537656 97710 88219 27 22 22261118 606015 0 2266009 22261118 606015 2266009 -13086621 -565430 0 -3903068 -18395 -16989689 -583825 0 5271429 22190 2266009 The development projects that the company is involved with, relate to the further development of the company's instrument platform based on its patented technology.The platform is to be used in life science research and development related to protein and particle quantification and characterization. In addition to the instrument platform, the projects also involve the development of accompanying kits and consumables. The projects are proceeding as planned. They are expected to contribute positively to future earnings. 4.Property, plant and equipmentFigures in DKKLeasehold improvementsOther fixtures and fittings, tools and equipmentCost as at 01.01.25335,7111,177,026Additions during the year01,578,861Cost as at 31.12.25335,7112,755,887Depreciation and impairment losses as at 01.01.25-232,264-898,874Depreciation during the year-67,143-202,381Depreciation and impairment losses as at 31.12.25-299,407-1,101,255Carrying amount as at 31.12.2536,3041,654,632 335711 1177026 1578861 335711 2755887 -232264 -898874 -67143 -202381 -299407 -1101255 36304 1654632 327815 17303 345118 345118 -835200 4455733 5173583 7.Other commitmentsLease commitmentsThe company has concluded lease agreements with terms to maturity of 13 months and total lease payments of DKK 628k. Other commitmentsThe company has entered into a binding agreement for the purchase of materials that will not be delivered until the next financial year. The agreement concerns the purchase of raw materials for DKK 4.157k. 8.Charges and securityThe company has issued mortgage deeds registered to the mortgagor in the total amount of DKK 5.000k secured upon goodwill relating to research and development, operating equipment and fixtures with a carrying amount of DKK 9.251k. The mortgage deeds registered to the mortgagor comprise a total of DKK 5.000k provided as security for debt to credit institutions. The annual report is presen­ted in ac­cord­ance with the provisions of the Danish Fi­nan­cial Statements Act (Årsregn­skabs­lov­en) for enterprises in re­port­ing class B with application of pro­vi­sions for a higher reporting class. Basis of recognition and measurementIncome is recognised in the income state­ment as earned, including value adjust­ments of fin­an­cial assets and liabilities. All ex­penses, including depreciation, amortisa­tion, impair­ment losses and write-downs, are also recognised in the in­come state­ment.Assets are recognised in the balance sheet when it is probable that future economic bene­fits will flow to the company, and the value of such assets can be measured reliably. Liabilities are recognised in the balance sheet when it is probable that future economic benefits will flow from the company, and the value of such liabilities can be measured reliably. On initial recognition, assets and liabilities are measured at cost. Subsequently, assets and liabilities are measured as described for each item below.On recognition and measurement, account is taken of foreseeable losses and risks arising before the date at which the annual report is presented and proving or disproving matters arising on or before the balance sheet date. CURRENCYThe annual report is presen­ted in Danish kroner (DKK).On initial recognition, transactions den­ominated in foreign currencies are trans­lated using the exchange rates applicable at the transaction date. Exchange rate differences between the exchange rate applicable at the transaction date and the exchange rate at the date of payment are recognised in the income statement as a financial item. Receivables, payables and other monetary items denominated in foreign currencies are translated using the exchange rates applicable at the balance sheet date. The difference between the ex­change rate applicable at the balance sheet date and at the date at which the receivable or payable arose or was recognised in the latest annual report is recognised under financial income or ex­penses in the income statement. Fixed assets, inventories and other non-monetary assets acquired in foreign currencies are translated using historical exchange rates. LEASESLease payments relating to operating leases are recognised in the income statement on a straight-line basis over the lease term. GRANTSGrants are recognised when there is reasonable certainty that the grant conditions have been met and that the grant will be re­ceived.Grants to cover expenses incurred are recog­nised on a proportionate basis in the in­come statement over the period in which the expenses eligible for grants are expensed. Grants are recognised under other operating income.Grants received for the production or con­struction of assets are recognised as deferred income under payables. For depreciable and amortisable assets, the grant is recognised as the asset is de­pre­ci­ated or amor­tised. Gross profitGross profit comprises rev­enue, work performed for own account and capitalised, other operating income and cost of sales and other external ex­penses. RevenueIncome from the sale of goods is recognised in the income statement if delivery has taken place and the risk has passed to the buyer before the end of the financial year and where the selling price can be determined reliably and is expected to be paid. Revenue is measured at fair value and is determined exclusive of VAT and other taxes collected on behalf of third parties and less discounts. Work performed for own account and capitalisedWork performed for own account and capitalised comprises cost of sales, wages and salaries and other internal expenses incurred during the year and included in the cost of self-constructed or self-produced intangible assets and property, plant and equipment. Other operating incomeOther operating income comprises income of a secondary nature in relation to the enterprise’s activities, including rental income, salary supplements and refunds, negative goodwill and gains on the sale of intangible assets and property, plant and equipment. Cost of salesCost of sales comprises cost of sales for the year measured at cost plus any changes in inventories, including write-downs to the extent that these do not exceed normal write-downs. Other external expensesOther external expenses comprise costs re­lating to distribution, sales and advertising and administration, premises and bad debts to the extent that these do not exceed normal write-downs. Staff costsStaff costs comprise wages and salaries as well as other staff-related costs. De­pre­ci­a­tion, amor­ti­sa­tion and impair­ment lossesThe de­pre­ci­a­tion and amor­ti­sa­tion of in­tan­gi­ble as­sets and prop­er­ty, plant and equip­ment aim at systematic de­pre­ci­a­tion and amor­ti­sa­tion over the expected useful lives of the assets. Assets are de­pre­ci­ated and amor­tised according to the straight-line method based on the following ex­pected useful lives and residual values:The basis of de­pre­ci­a­tion and amor­ti­sa­tion is the cost of the asset less the expected residual value at the end of the useful life. Moreover, the basis of de­pre­ci­a­tion and amor­ti­sa­tion is reduced by any impairment losses. The useful life and residual value are determined when the asset is ready for use and reassessed annually.In­tan­gi­ble as­sets and prop­er­ty, plant and equip­ment are impaired in accordance with the accounting policies referred to in the ‘Impairment losses on fixed assets’ section. Other net financialsInterest income and interest expenses, for­eign exchange gains and losses on trans­ac­tions denominated in foreign currencies etc. are recognised in other net financials. Tax on profit/loss for the yearThe current and deferred tax for the year is recognised in the income statement as tax on the profit/loss for the year with the portion attributable to the profit/loss for the year, and directly in equity with the portion attributable to amounts recognised directly in equity. Intangible assetsCompleted de­vel­op­ment projects and de­vel­op­ment projects in progressDevelopment projects are recognised in the balance sheet where the project aims at developing a specific product or a specific process, intended to be produced or used, respectively, by the company in its production process. On initial recognition, development projects are measured at cost. Cost comprises the purchase price plus expenses resulting directly from the purchase, including wages and salaries directly attributable to the development projects until the asset is ready for use. Interest on loans arranged to finance development projects in the development period is not included in the cost. Other development projects and development costs are recognised in the income statement in the year in which they are incurred.Development projects in progress are trans­ferred to completed development projects when the asset is ready for use. Development projects are subsequently measured in the balance sheet at cost less accumulated amortisation and impairment losses.Completed development projects are amortised using the straight-line method based on useful lives, which are stated in the ‘De­pre­ci­a­tion, amor­ti­sa­tion and impair­ment losses’ section.Acquired rightsAquired rights are measured in the balance sheet at cost less accumulated amortisation and impairment losses.Acquired rights are amortised using the straight-line method based on useful lives, which are stated in the ‘De­pre­ci­a­tion, amor­ti­sa­tion and impair­ment losses’ section.Gains and losses on the disposal of intangi­ble assetsGains and losses on the disposal of intangible assets are determined as the difference between the selling price, if any, less selling costs and the carrying amount at the date of disposal. Property, plant and equipmentProperty, plant and equipment comprise leasehold improvements as well as other fixtures and fittings, tools and equipment.Property, plant and equipment are meas­ured in the balance sheet at cost less accumulated depreciation and impairment losses. Cost comprises the purchase price and expenses resulting directly from the purchase until the asset is ready for use. Interest on loans arranged to finance production is not included in the cost.Property, plant and equipment are depreci­ated using the straight-line method based on useful lives and residual values, which are stated in the ‘De­pre­ci­a­tion, amor­ti­sa­tion and impair­ment losses' section.Gains and losses on the disposal of property, plant and equipment are determined as the difference between the selling price, if any, less selling costs and the carrying amount at the date of disposal less any costs of disposal. Impairment losses on fixed assetsThe carrying amount of fixed assets which are not measured at fair value is assessed annually for indications of impairment over and above what is reflected in de­pre­ci­a­tion and amor­ti­sa­tion.If the company's realised return on an asset or a group of assets is lower than expected, this is considered an indication of impairment.If there are indications of impairment, an impairment test is conducted of individual assets or groups of assets.The assets or groups of assets are impaired to the lower of recoverable amount and carrying amount.The higher of net selling price and value in use is used as the recoverable amount. The value in use is determined as the present value of expected net cash flows from the use of the asset or group of assets as well as expected net cash flows from the sale of the asset or group of assets after the expiry of their useful lives.Impairment losses are reversed when the reasons for the impairment no longer exist. InventoriesInventories are measured at cost calculated according to the FIFO-method. Inventories are written down to the lower of cost and net realisable value.The cost of raw materials and consumables as well as goods for resale is determined as purchase prices plus expenses resulting directly from the purchase.The net realisable value of inventories is determined as the selling price less costs of completion and costs necessary to make the sale and is determined taking into account marketability, obsolescence and the expected development in the selling price. ReceivablesReceivables are measured at amortised cost, which usually corresponds to the nom­inal value, less write-downs for bad debts.Write-downs for bad debts are determined based on an individual assessment of each receivable if there is no objective evidence of individual impairment of a receivable.Deposits recognised under assets comprise deposits paid to the lessor under leases entered into by the company. PrepaymentsPrepayments recognised under assets com­prise costs incurred in respect of subse­quent financial years. CashCash includes deposits in bank account. EquityAn amount equivalent to internally generated development costs in the balance sheet is recognised in equity under reserve for development costs. The reserve is measured less deferred tax and reduced by amortisation and impairment losses on the asset. If impairment losses on development costs are subsequently reversed, the reserve will be restored with a corresponding amount. The reserve is dissolved when the development costs are no longer recognized in the balance sheet, and the remaining amount will be transferred to retained earnings. Current and deferred taxCurrent tax payable and receivable is recognised in the balance sheet as tax computed on the basis of the taxable income for the year, adjusted for tax paid on account.Deferred tax liabilities and tax assets are recognised on the basis of all temporary differences between the carrying amounts and tax bases of assets and liabilities. However, deferred tax is not recognised on temporary differences relating to goodwill which is non-amortisable for tax purposes and other items where temporary differ­ences, except for acquisitions, have arisen at the date of acquisition without affecting the net profit or loss for the year or the tax­able income. In cases where the tax value can be determined according to different taxation rules, deferred tax is measured on the basis of management’s intended use of the asset or settlement of the liability.Deferred tax assets are recognised, following an assessment, at the expected realisable value through offsetting against deferred tax liabilities or elimination in tax on future earnings.Deferred tax is measured on the basis of the tax rules and at the tax rates which, according to the legislation in force at the balance sheet date, will be applicable when the deferred tax is expected to crystallise as current tax. PayablesLong-term payables are measured at cost at the time of contracting such liabilities (raising of the loan). The payables are subsequently measured at amortised cost where capital lossesand loan expenses are recognised in the income statement as a financial expense over the term of the payable on the basis of the calculated effective interest rate in force at the time of contracting the liability.Short-term financial payables are measured at amortised cost, normally corresponding to the nominal value of such payables. Other short-term payables are measured at net realisable value. Deferred incomeDeferred income under liabilities comprises payments received in respect of income in sub­sequent financial years.